Lakewood Capital Management’s Charles River Laboratories CRL Stock Holding History

Lakewood Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.9M	Sell	69,000 -71,240	-51%	-$13.2M	0.75%	40
2025 Q4	$28M	Hold	140,240	–	–	1.85%	23
2025 Q3	$21.9M	Hold	140,240	–	–	1.66%	23
2025 Q2	$21.3M	Hold	140,240	–	–	1.59%	23
2025 Q1	$21.1M	Buy	140,240 +28,500	+26%	+$4.78M	1.84%	20
2024 Q4	$20.6M	Hold	111,740	–	–	1.85%	21
2024 Q3	$22M	Hold	111,740	–	–	1.73%	22
2024 Q2	$23.1M	Sell	111,740 -1,000	-0.9%	-$227K	1.89%	19
2024 Q1	$30.5M	Sell	112,740 -5,000	-4%	-$1.19M	2.49%	16
2023 Q4	$27.8M	Buy	117,740 +30,000	+34%	+$5.9M	2.33%	17
2023 Q3	$17.2M	Hold	87,740	–	–	1.56%	22
2023 Q2	$18.4M	Hold	87,740	–	–	1.6%	21
2023 Q1	$17.7M	Hold	87,740	–	–	1.45%	23
2022 Q4	$19.1M	Sell	87,740 -18,000	-17%	-$3.93M	1.7%	21
2022 Q3	$20.8M	Sell	105,740 -39,000	-27%	-$8.42M	1.75%	20
2022 Q2	$31M	Buy	144,740 +67,640	+88%	+$16.5M	1.92%	24
2022 Q1	$21.9M	Buy	+77,100	New	+$23.8M	1.1%	31
2021 Q3	–	Sell	-124,000	Closed	-$45.9M	–	58
2021 Q2	$45.9M	Sell	124,000 -39,000	-24%	-$13M	1.89%	22
2021 Q1	$47.2M	Sell	163,000 -14,000	-8%	-$3.89M	2%	20
2020 Q4	$44.2M	Sell	177,000 -21,000	-11%	-$5M	2.07%	20
2020 Q3	$44.8M	Sell	198,000 -27,000	-12%	-$5.6M	2.16%	18
2020 Q2	$39.2M	Buy	+225,000	New	+$35.9M	1.69%	22

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lakewood Capital Management's CRL Position: Q1 2026 in Review

Lakewood Capital Management reduced its Charles River Laboratories (CRL) stake by 51% in Q1 2026, selling an estimated $13.2M and leaving 69,000 shares worth $11.9M. The position accounts for 0.75% of the portfolio, ranked #40.

Lakewood Capital Management first reported a position in CRL in Q2 2020 and has held it in 22 quarters since. The position peaked at $47.2M in Q1 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Lakewood Capital Management held 69,000 shares of Charles River Laboratories worth $11.9M as of Q1 2026.
Lakewood Capital Management sold 71,240 Charles River Laboratories shares in Q1 2026, an estimated $13.2M.
Charles River Laboratories made up 0.75% of Lakewood Capital Management's portfolio in Q1 2026, its #40 holding.
Lakewood Capital Management first reported a position in Charles River Laboratories in Q2 2020 and has held it in 22 quarters since.
Lakewood Capital Management's Charles River Laboratories position peaked at $47.2M in Q1 2021.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Lakewood Capital Management's 13F filing for Q1 2026, filed 15 May 2026.